Literature DB >> 109112

Effect of lipophilicity of nitroimidazoles on radiosensitization of hypoxic bacterial cells in vitro.

R F Anderson, K B Patel.   

Abstract

The effect of radiosensitization of hypoxic bacterial cells by 9 nitroimidazoles was measured in the bacterial strains E. coli AB 1157 and S. lactis 712. Seven of these compounds were similar to misonidazole in their redox properties, but differed widely in their lipophilicites. The dependence of sensitization enhancement on reduction potential was similar to that reported in mammalian cells. The efficiency of sensitization was similar for compounds of low lipophilicity, but increased if the octanol: water partition coefficients of the compounds were higher than about 3.5. With one compound, otherwise similar to misonidazole, the increased lipophilicity led to about one order of magnitude lower concentration achieving the same degree of radiosensitization.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 109112      PMCID: PMC2009997          DOI: 10.1038/bjc.1979.124

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  7 in total

1.  Electron affinic sensitization. V. Radiosensitization of hypoxic bacteria and mammalian cells in vitro by some nitroimidazoles and nitropyrazoles.

Authors:  J C Asquith; M E Watts; K Patel; C E Smithen; G E Adams
Journal:  Radiat Res       Date:  1974-10       Impact factor: 2.841

2.  Nitroimidazole derivatives. Relationship between structure and antitrichomonal activity.

Authors:  K Butler; H L Howes; J E Lynch; D K Pirie
Journal:  J Med Chem       Date:  1967-09       Impact factor: 7.446

3.  Repair of a DNA complex from x-irradiated Chinese hamster cells.

Authors:  M M Elkind; C M Chang-Liu
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1972-07

4.  Effects of ionizing radiation on bacterial DNA-membrane complexes.

Authors:  W A Cramp; D K Watkins; J Collins
Journal:  Nat New Biol       Date:  1972-01-19

5.  Electron-affinic sensitization. VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers.

Authors:  G E Adams; I R Flockhart; C E Smithen; I J Stratford; P Wardman; M E Watts
Journal:  Radiat Res       Date:  1976-07       Impact factor: 2.841

6.  Radiosensitization of Serratia marcescens by bipyridinium compounds.

Authors:  R F Anderson; K B Patel
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1977-11

7.  Structure-activity relationships in the development of hypoxic cell radiosensitizers. I. Sensitization efficiency.

Authors:  G E Adams; E D Clarke; I R Flockhart; R S Jacobs; D S Sehmi; I J Stratford; P Wardman; M E Watts; J Parrick; R G Wallace; C E Smithen
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1979-02
  7 in total
  5 in total

1.  Dose-dependence and related studies on the pharmacokinetics of misonidazole and desmethylmisonidazole in mice.

Authors:  P Workman
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

2.  Radiosynthesis of the tumor hypoxia marker [18F]TFMISO via O-[18F]trifluoroethylation reveals a striking difference between trifluoroethyl tosylate and iodide in regiochemical reactivity toward oxygen nucleophiles.

Authors:  Makiko Suehiro; Guangbin Yang; Geralda Torchon; Ellen Ackerstaff; John Humm; Jason Koutcher; Ouathek Ouerfelli
Journal:  Bioorg Med Chem       Date:  2011-02-18       Impact factor: 3.641

3.  Structure-pharmacokinetic relationships for misonidazole analogues in mice.

Authors:  P Workman; J M Brown
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

4.  Preclinical pharmacokinetics of benznidazole.

Authors:  P Workman; R A White; M I Walton; L N Owen; P R Twentyman
Journal:  Br J Cancer       Date:  1984-09       Impact factor: 7.640

5.  Enhancement of the effect of cytotoxic drugs by radiosensitizers.

Authors:  W M Martin; N J McNally; J De Ronde
Journal:  Br J Cancer       Date:  1981-06       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.